Back to results
US 2015/0144129 A1Published application
Nasal administration
AssigneeOptiNose AS
InventorsPer Gisle DJUPESLAND, Ramy A. MAHMOUD, John MESSINA
Life of this patent
Estimating the term…
Abstract
A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject.
Claims23
A method of therapeutically treating a patient, comprising:
- administering, in a first step, a therapeutic agent;
- and
- delivering, in a second step, to a location at an interior of a nasal passage of the patient a therapeutic amount of at least one of carbon dioxide or a pH adjusting material, wherein the first step is performed at least one of before, after, before and after, and at the same time as the second step.
23-80. (canceled)
Dependencies are inferred from the claim text.